XRF Scientific's Rare Stumble Was a Timing Issue, Not a Demand Problem
A first-half miss on softer consumables sales rattled a decade-long consistent grower, before a strong third-quarter re-acceleration confirmed the underlying business remains intact.
15 Oct 2026 · 3 min read
In short
XRF Scientific delivered a rare miss to broker consensus in its first-half FY26 result, with consumables revenue falling 13% on the prior year, even though the company has now grown profits across 10 consecutive reporting halves.
Seneca Financial Solutions attributes the weakness to a timing effect, since large offshore customers tend to place bulk orders every 12-18 months, rather than any genuine change in underlying demand.
Third-quarter revenue growth re-accelerated to 13.8% from 9.1% in the first half, with record orders in hand and a small acquisition of a Combustion Gas Analysis business from Bruker Corporation.
XRF Scientific delivered a rare disappointment for a business with a decade-long track record of consistent profit growth, missing broker consensus by 6 percent on softer consumables sales in its first half, before fund managers concluded the weakness reflected customer order timing rather than any genuine change in demand, and a strong third-quarter re-acceleration confirmed the underlying business remains intact.
A rare miss for a consistent grower
Naos Asset Management said one of the more disappointing share price reactions of the period occurred in a business that has historically delivered consistent revenue and profit growth, with first-half FY26 profit growth of around 4 percent, a modest result that came in roughly 6 percent below the sole stockbroker's consensus forecast, even though XRF has now grown profits in absolute terms across ten consecutive reporting halves. Merewether Capital said revenue rose 9 percent to $31.1 million and net profit rose 6 percent to $5.3 million, a solid result especially given a weaker than expected first quarter offset by a strong second quarter, with the leading cause of weakness in the core, high-margin Consumables segment, where revenue fell 13 percent on the prior year, with management pointing to specific customer order timing issues.
XRF has now grown profits in absolute terms across 10 consecutive reporting halves. In 1HFY26, XRF delivered profit growth of approximately 4%, though this came in roughly 6% below the sole stockbroker's consensus forecast.
— Naos Asset Management, Quarterly Report, March 2026
A timing effect, not a demand problem
Seneca Financial Solutions said the stock declined following the result as investors focused on softer consumables sales growth, but its own analysis suggests this reflects a timing effect rather than any change in underlying demand, since several large offshore customers tend to place bulk orders every 12 to 18 months to reduce customs and logistics costs, creating uneven reported revenue. Seneca described XRF as a small-cap industrial technology business supplying equipment used in mineral testing, with a $250 million market cap, profitable and growing, having delivered 26 percent compound annual growth in profit over the past five years, with its appeal lying in a recurring revenue model where laboratories purchase testing machines and then continue buying the consumables required.
Several large offshore customers tend to place bulk orders every 12-18 months to reduce customs and logistics costs, which can create uneven reported revenue. XRF has delivered 26% compound annual growth in profit over the last five years.
— Seneca Financial Solutions, Monthly Report, February 2026
A strong re-acceleration confirms the thesis
Merewether Capital said XRF saw a re-acceleration of revenue growth after the slower first half, with third-quarter revenue growing 13.8 percent compared with 9.1 percent through the first half, and commentary supportive of a strong finish to the financial year with record orders in hand, alongside a small acquisition of a Combustion Gas Analysis business from Bruker. Naos Asset Management described XRF as a globally recognised manufacturer and distributor providing niche products to mining and industrial laboratories in more than 80 countries, with multiple growth levers across new products, distribution channels and acquisitions, having acquired the Combustion Gas Analysis business from Bruker Corporation for upfront US$4 million in cash, paying around 1 times revenue including earn-out for a product line non-core to Bruker.
What fund managers say they are watching next is continued conversion of the record order book, integration of the Combustion Gas Analysis acquisition from Bruker, whether the recurring consumables revenue model reasserts its typical growth pattern following the customer-timing-driven wobble, and delivery of further growth across new products, distribution channels and acquisitions.
Questions
Why did XRF Scientific miss broker expectations in its first half?
XRF Scientific's first-half FY26 profit growth of around 4% missed broker consensus by roughly 6%, driven by a 13% fall in Consumables segment revenue, which management attributed to specific customer order timing issues.
Was XRF Scientific's consumables revenue decline a genuine demand problem?
Seneca Financial Solutions argues it was more likely a timing effect, since several large offshore customers tend to place bulk orders every 12-18 months to reduce customs and logistics costs, creating uneven reported revenue rather than a real change in demand.
How did XRF Scientific's growth trend after the weak first half?
XRF Scientific's third-quarter revenue growth re-accelerated to 13.8% from 9.1% in the first half, with record orders in hand and a small complementary acquisition of a Combustion Gas Analysis business from Bruker Corporation.
5 managers, 17 comments, with each manager's latest recorded position.
See XRF